SCHEMBL25003584

SCHEMBL25003584

C=C(CCF)N(C)C(=O)c1cc2ccnc(C)c2n1C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.32
DYRK1A Q13627 6/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25003511 0.88 SYK (0.35) SYK
SCHEMBL25002664 0.80 DYRK1A (0.33) DYRK1A
SCHEMBL25003585 0.72
SCHEMBL24896374 0.72 MCL1 (0.46) DYRK1A
SCHEMBL24896270 0.72 SYK (0.32) SYK
SCHEMBL25002510 0.68 SYK (0.35) SYK
SCHEMBL25002506 0.67 PHGDH (0.33) SYK
SCHEMBL25002464 0.67 LMNA (0.30)
SCHEMBL24896261 0.66 GRM4 (0.39)
SCHEMBL24896576 0.64 MCL1 (0.43) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230039586-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230039586-A1 BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 SYK 4883/4885DYRK1A 3483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.